Sitemap - 2021 - The California Stem Cell Report

California Stem Cell Report On a Holiday Break

Jakob's Dream: 'Mud in My Teeth...Finally Be Free'

California, Orchard Therapeutics and the 'Bubble Baby' Treatment: No Progress Announced Last Week

Pace of State Spending in California on Cell/Gene Therapy? $38K an Hour

A Stem Cell Peek into 2022: California Set to Spend a Half-Billion or So

Life After Proposition 14: California Stem Cell Agency's Take on Its First Year with $5.5 Billion

This is Not a Stem Cell Item

CIRM Headquarters Move Attracts a Bit of Media Attention

The Orchard/UCLA/CIRM Bubble Baby Saga and 20 Children: Likely Resolution This Month

New Home for California's Stem Cell Agency

California Stem Cell Research Spending to Hit Nearly $500 Million by End of June

Breaking Down Barriers to ‘Living Medicines:’ California’s New Plan to Partner with Industry to Manufacture ‘Transformative’ Treatments

From Affordability of Million-Dollar Treatments to IP on State-Backed Research, It's All on the Table This Week in the Golden State

California Hands Out $48 Million for Stem Cell Research

Looking Back at Geron and CIRM: How the Allure of a Scientific Breakthrough Led to Dubious Practices

From Spinal Cord Injury to Heart Disease: Geron, Tom Okarma, CIRM Coming Together -- Sort Of

Poseida Therapeutics and CIRM: Company Moving Away from $20 Million Cancer Trial Backed by California

Reader Royalty Comment: A General Fund Matter

California Stem Cell Royalties: A Mere Half-Million Dollars, But Likely to Grow

California Stem Cell Performance Audit: Oversight Panel Postpones Action until Spring

This is Not a Stem Cell Item

Improvements Needed: So Says a Performance Audit of $12 Billion California Stem Cell Agency

How is California's Stem Cell Agency Doing? Accountability Review Next Week, but Missing From the Agenda is the Recent Performance Audit

Bringing Cell and Gene Therapy to the Hinterlands of California

Text of Proposition 14 Requiring Creation of Community Care Centers of Excellence

Stem Cell Data Deluge: California Looking for "Real World" Ways to Speed Cures

Need Work? Would You Like to Help Give Away Money?

What is a “CIRM?” And is it Zeroing in on Cures or Boiling the Ocean?

Correction

Affordability of $2 Million Cell/Gene Therapies: California Set to Start Work on Problem Within the Next Month

Ballot Campaigns and Bad Knees: What They Mean for California Cell and Gene Therapy Research

Looking out at Five Years of Billions in California Stem Cell Research Spending

Quote of the Day

More Info on Cartilage/Arthritis Story and $9 Million California Research Effort

Attack on Cartilage Damage and Arthritis: California Adds $6 Million to Effort

Delivering the Stem Cell Goods: California's Targets for the Next Five Years

Does the $12 Billion California Stem Cell Agency Manage Its Investments?

California's Multi-Billion Dollar Plan for Spending on Cell and Gene Therapy Is Nearing Completion

California's $12 Billion Stem Cell Agency Moving to Weaken its Own Conflict of Interest Regulations

Correction

"Leaving the Room" and Conflicts of Interest at California's Stem Cell Agency

'Deeply Flawed' Ethical Reviews and Clinical Trials: Something for California to Chew On

Safety Scares, Gene Therapy and California's Multibillion-Dollar, Stem Cell Agency

Quick Step Pace at California's Stem Cell Agency: $98 Million Awarded in 47 minutes and 12 Seconds

Correction

What is a California ARS? And How Can It Give Away Billions of Dollars?

This Is Not a Stem Cell Item

Sickle Cell Disease and Astronomical Costs for a Cure

Prices, Profits, 'Magical Cures': California Stem Cell Agency Tackles Affordability of Million-Dollar Treatments

Diving Into the California Stem Cell Agency's New Affordability Program for Cell and Gene Therapies

Cell and Gene Therapies: Text of Rules for California's Affordability and Access Program

Digging into March-In: Appealing Concept for Some, But Anathema to Others

California's Stem Cell Agency Highlights Three Researcher/Recipients

California Needs Help in Giving Away $5.5 Billion for Stem Cell and Gene Therapy Research

Rogue Stem Cell Clinics, CIRM and the Feds

Twenty Children Wait for Cure While Efforts to Revive Abandoned Bubble Boy Clinical Trial Creep Along

Texts of Questions about the Bubble Boy Clinical Trial and CIRM’s Response (August 2021)

Texts of Questions about the Bubble Boy Clinical Trial and UCLA’s Response (August 2021)

Texts of Orchard Response and Questions regarding the Bubble Baby Treatment plus Related SEC Filings (August 2021)

California Stem Cell Agency Hits 75 Clinical Trials, Adds Three Today

Quote of the Day

$12 Million California Stem Cell Award Round: Two More Scientists Appeal Reviewer Rejections

$4 Million California Investment in "Killer' Cells Goes Awry

$43 Million More for California Stem Cell Research Ranging from Strokes to Heart Failure

Want to Help Give Away $5 Billion? Now is Your Chance in California

Bluebird bio's $1.8 Million Setback on Gene Therapy: Is It a Growing Sign of Rejection of Reimbursement Profit Models?

Bluebird Pinched in Europe; Implications for California Genetic Research

'Socialized Research' and 'Privatized Profits:" California's Gene Therapy Research and Million Dollar Plus Treatments

Quote of the Day: Peer Review

Turning High School Students On To Stem Cell Science: California's $9 Million Effort

Job Openings for Folks Who Want to Turn Stem Cells into Cures

California Stem Cell Agency Hits $50 Million in Battle Against Sickle Cell Disease

Northern California Spinal Cord Patient Advocate appointed to State Stem Cell Agency Board

A Mother of a SCID Toddler Speaks Out on Awareness, Bravery and Legacies

California Pops for $51 Million in Stem Cell Training

$48 Million Going for California Stem Cell Training; 93 Percent Success Rate for Award Applicants

Patient Protection, Rogue ‘Stem Cell’ Clinics, California’s Medical Regulators and $18.6 Million

Subscribe Now to the California Stem Cell Report: Independent, 'Authoritative,' 'Indispensable'

Building a New Team in California to Spend $5.5 Billion on Stem Cell Research, Gene Therapy, Affordability and More

Thomas Rando Departing Stanford to Head UCLA's Stem Cell Center

Looking For Work? California's Stem Cell Agency Is Offering Cutting Edge Opportunities

SCID Patient Advocate Reminds Us that Bubble Baby Term Has Nuances

Orchard and Bubble Baby Cure: Restart of Life-Saving Clinical Trial Not on Near Horizon

The $5 Billion California Stem Cell Story: How You Can Get Some

Bringing Joy Back to the Party: Blindness, Diabetes and $114 Million from California Stem Cell Agency

California's $118 Million Investment Seeking a Stem Cell Cure for Diabetes: Latest News

The 'UC Caucus:' The Largest Voting Bloc at the California Stem Cell Agency

Attention Scientists: Time to Learn about Snagging Millions in California Stem Cell Cash

California's Adds $12 Million to its $80 Million Fight Against Lou Gehrig's Disease

Gene Therapy Research Slated to Become Normal Fare for California Stem Cell Agency

Orchard Therapeutics: A 'Discreet Axing' of Bubble Baby Treatment

Subscribe Free Today to the California Stem Cell Report -- - The Most Comprehensive Source for the Ins and Outs of California's $12 Billion Stem Cell Program

Recalling a 2012 California Alzheimer's Effort: A Case of 'Clutching at Straws'Says LA Times Columnist

California Researcher Loring on Rogue Clinics Tarnishing Legitimate Stem Cell Work

Feds Crack Down on Rogue Stem Cell Clinics; California Remains Unhurried

'Father' of California Stem Cell Agency Slated for National Award Next Week

California Stem Cell Agency Withholds $5.8 Million from Orchard in Bubble-Baby Flap

California to Spend $41,000 an Hour on Stem Cell Research

This Is Not a Stem Cell Item

Orchard Therapeutics Exits the Bubble Baby Treatment Business; Decision Praised by Parents

Text of Maria Millan's Statement on the Orchard Bubble Baby Decision

Text of UCLA statement on Orchard Bubble Baby Decision

Text of Parents' Comments on Orchard's Bubble Baby Decision

Orchard Exits Life-Saving Bubble-Baby Research in Wake of Flap Over Patient Access

Text of Orchard's Announcement Terminating its Bubble-Baby Treatment License

Three Bubble-Baby Families, Multimillion-Dollar Negotiations, California's Stem Cell Agency and Life and Death

Text of UCLA Response to Questions about Orchard Bubble Baby Affair

Bubble Baby Families Denied 'Compassionate Use' of Life-Saving Therapy

Text of "SOS" Letter from Families of Bubble Baby Children

Text of Comments Seeking Release of Life-Saving Bubble Baby Treatment to State of California

Read All About It: Bubble Babies Hit by Suspension of Trial for Genetic Cure; California Taxpayers Paying for Trial

Bubble Baby Cancellation Story Draws Attention in California's Largest Newspaper

Orchard's Suspension of Bubble Baby Disease Trial Earns Sharp Rebuke

Can a California 'March-In' Save Terminally Ill 'Bubble Babies?'

Text of NAM March-in Comments in California Stem Cell Study

Orchard Bubble Baby Stories and Growing Interest in California Stem Cell News

California Stem Cell Agency Approves $14.5 Million to Fight Cancer

A New Opening for Patient Advocates, Researchers to Pitch California's $12 Billion Stem Cell Agency

California Stem Cell Agency Pledges to Do "Everything" to Salvage Cure for Bubble Baby Disease

'Wicked' Problems, Orchard Therapeutics and Bubble Babies: A California Stem Cell Story

Good News for 'Bubble Babies'and California Stem Cell Agency -- With an Asterisk

Tailoring Stem Cell Info: Different Audiences, Different Needs

California Directors Tighten Up on $12 Million for State Stem Cell Programs

California Stem Cell Agency Says No Taxpayer Cash Went for Monkey-Human Embryos

Going Dark: The California Stem Cell Report is Taking a Break for 10 Days

Accountability, Oversight and More Needed: A Brief Critique of the California Stem Cell Program from a Biotech CEO 

Essential Reading on California's Ground-Breaking, $12 Billion, Stem Cell/Gene Therapy Research Program

It's Essential Reading; Subscribe Today to the California Stem Cell Report

California's Sickle Cell Surge: Researchers Tackle Disease with First-Ever, Gene-Editing Clinical Trial

This Is Not a Stem Cell Item

A Covid Score for California's Stem Cell Research Effort

Friday March 26, 2021

'Boiling the Ocean:' California Wrestles with Billion-Dollar Decisions and Stem Cell Research

How Does a CIRM Work? California's Stem Cell Agency Offers Up Trail Guide to Its Ambitious $12 Billion Program

What Do California Voters Want from Their Stem Cell Agency’s Multibillion-Dollar Smorgasbord?

CIRM Panel Tweaks Selection of Grant Judges, Praises Their Work

A Critical Perspective from a Blue Ribbon Study of California's Stem Cell Awards Process

The Latest: Deciding who Decides Who Gets California's Stem Cell Billions

Who Should be a Stem Cell Judge for California's $12 Billion Research Agency?

This Is Not a Stem Cell Item

California's Billion Dollar Gatekeepers: Changes Coming for Those Who Decide Who Gets the Cash?

Subscribe Today to the Leading Source of Information on a $12 Billion Source of Stem Cell Research Funding

Telling the California Stem Cell Story: A Matter of Billions of Dollars

Bulldogs and Babies: World's First Trial to Treat Spina Bifida in the Womb

California Stem Cell Flashback: When CIRM Was Homeless and Without an HQ

A California Stem Cell Flashback: Finding a Place to Call a Headquarters

Drilling Into $165 Million: How much does a CIRM Scholar Cost?

BioCom California/CIRM Peddle Golden Stem Cell Opportunities Next Week

$165 Million for Stem Cell Education and Training in California

California Approves $165 Million for Stem Cell Training and Education

"California's Great Stem Cell Experiment: Inside a $3 Billion Search for Cures"

"Hotel California" for Golden State Stem Cell Research? Plus the Bad Tidings on a $16 Million Clinical Trial Investment

A CIRM 'Hotel California'for Stem Cell Research? But Bad News in a California Stem Cell Trial

Text of Statement by Amander Clark of UCLA on Future Direction of California's Stem Cell Program

California's $212 Million Investment in Gene Therapy and Bad News from bluebird

California Stem Cell Experts to Lay Out Possibilities for Spending $5.5 Billion

The Growing California Stem Cell Board

This Is Not a Stem Cell Item

Looking for Work? California's Stem Cell Agency Needs 11 Good People

Looking for Work? California's Stem Cell Agency Needs 11 Good People

Don't Miss Critical Information and News about California's $12 Billion Stem Cell Program

California Stem Cell Agency Expected to Restart $100 Million in College Training Programs

Looking for Some of California's Stem Cell Billions? Here is Where to Start.

Questions on New $5.5 Billion Direction of California Stem Cell Agency

Chewing Through Concrete: Moderna, Hit Rates and a former California Stem Cell Scholar

CIRM Lays Out New Path: Funding More Buildings, More Research and Into New Territories (Personalized Medicine, Therapy Delivery)

California Stem Cell Agency Lays Out Its New Direction

Plus and Minuses: The Proposition 14 "Christmas Tree" and its Implications

Pluses and Minuses: The New Look at California's $12 Billion Stem Cell Program

New Home for California Stem Cell Report -- Don't Miss an Item

The Charter of the California Stem Cell Agency and the U.S. Constitution: A Brief Comparison

California Stem Cell Conflicts of Interest and Their Regulation Rise Next Week

California Stem Cell Agency Eyes Conflict-of-Interest Rules for New, Advisory Groups

Text of Language Dealing with Advisory Task Forces of the California Stem Cell Agency

California Stem Cell Board Faces its Future in Late January Meeting

California's Stem Cell Agency's Future

The Golden State's $12 billion stem cell research program

California's $12 Billion Stem Cell Agency and Fresh Ruckus over Conflicts of Interest

Recipient of $22 Million from California's Stem Cell Program Named to Its Board

Hundreds of California Scientists Eyeing $182 Million from Golden State Taxpayers

Looking for Some Research Cash? $182 Million on Table in California; Briefing Thursday on How to Get It